Company / Revenue per Share
ResMed Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$35.03
FY2025
5-year range
$22.06 / $35.03
FY2021-FY2025
Trend
+10.0%
vs FY2024
Sector context
#54 of 147
Health Care
What the data says
At $35.03, ResMed's revenue per share ranks #54 of 147 in the Health Care sector. Revenue per Share has increased for 9 consecutive years, from $13.09 in FY2016 to $35.03 in FY2025.
Based on SEC 10-K filings.
35.03 in FY2025 with a 5-year CAGR of +11.2%.
Improved from $28.84 to $35.03 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +12.6%
- 5-Year CAGR
- +11.2%
- 10-Year CAGR
- -
Sector benchmark
#54 of 147 in Health CareTop 37% of 147This company $35.03 Sector average $127.83
▼
-72.6% below sector average
Key checks
Key Insights
- ResMed's revenue per share has grown for 9 consecutive years.
- In FY2025, revenue per share increased 10.0% year-over-year.
- Ranks #54 out of 147 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $35.03 | +10.0% |
| FY2024 | $31.86 | +10.5% |
| FY2023 | $28.84 | +17.4% |
| FY2022 | $24.57 | +11.3% |
| FY2021 | $22.06 | +7.2% |
| FY2020 | $20.58 | +12.7% |
| FY2019 | $18.27 | +11.0% |
| FY2018 | $16.46 | +12.0% |
| FY2017 | $14.69 | +12.3% |
| FY2016 | $13.09 | +9.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026